AM Investment Strategies’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY.RT
JCI
BC
TNB
WAM
IAIM
AM Investment Strategies's BMY.RT Position: Q1 2021 in Review
AM Investment Strategies sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 11,300 shares — an estimated $8K sold.
AM Investment Strategies first reported a position in BMY.RT in Q3 2020 and held it in 2 quarters. The position peaked at $25K in Q3 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.
- AM Investment Strategies reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
- AM Investment Strategies sold 11,300 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $8K.
- AM Investment Strategies first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q3 2020 and held it in 2 quarters.
- AM Investment Strategies's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $25K in Q3 2020.
- 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.
Based on AM Investment Strategies's 13F filing for Q1 2021, filed 26 Apr 2021.